CSIMarket
 
Medinotec Inc   (MDNC)
 

Medinotec Inc's Customers Performance

MDNC



 
MDNC's Source of Revenues During the corresponding time, Medinotec Inc recorded a revenue increase by 24.23 % year on year, sequentially revenue grew by 45.49 %. While revenue at the Medinotec Inc 's corporate clients

List of MDNC Customers




for the same period Medinotec Inc recorded revenue increase by 24.23 % year on year, sequentially revenue grew by 45.49 %.

List of MDNC Customers

Medinotec Inc's Business Units
Outside USA Internally Designed Manufactured Sales    8.11 % of total Revenue
Outside USA Distribution Agreement Sales    81.33 % of total Revenue
Inside USA Internally Designed Manufactured Sales    10.56 % of total Revenue
Inside The United States    10.56 % of total Revenue
Outside The United States    89.44 % of total Revenue






Medinotec Inc's Comment on Sales, Marketing and Customers



The Company operates in specialized markets including cardiology, renal dialysis, and niche surgical units. It maintains distribution agreements with third-party medical device companies for cardiology and renal dialysis products, managed by DISA Medinotec Proprietary Limited. DISA Life Sciences was appointed as a South African sub-distributor to support sales, marketing, and distribution of certain internally manufactured products within South Africa. The Company previously collaborated with Innovative Outcomes to develop U.S. distribution infrastructure for the Trachealator product, which received FDA clearance in November 2021; this relationship ended due to diverging market focuses.





Medinotec Inc’s Comment on Sales, Marketing and Customers


The Company operates in specialized markets including cardiology, renal dialysis, and niche surgical units. It maintains distribution agreements with third-party medical device companies for cardiology and renal dialysis products, managed by DISA Medinotec Proprietary Limited. DISA Life Sciences was appointed as a South African sub-distributor to support sales, marketing, and distribution of certain internally manufactured products within South Africa. The Company previously collaborated with Innovative Outcomes to develop U.S. distribution infrastructure for the Trachealator product, which received FDA clearance in November 2021; this relationship ended due to diverging market focuses.








MDNC's vs. Customers, Data

(Revenue and Income for Trailing 12 Months, in Millions of $, except Employees)



COMPANY NAME MARKET CAP REVENUES INCOME EMPLOYEES
Medinotec Inc 58.78 9.73 0.79 -
SUBTOTAL 0.00 0.00 0.00 -

Sources: Medinotec Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on:
Focus of this report: Medinotec Inc’s corporate clients.
For your research, we’ve provided 9 tables on Medinotec Inc corporate clients.
You can find them in the navigation menu under Customers & Markets.
To download the tables, please subscribe.



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.